Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/27145

Title:	Fibroblast Growth Factor 21 (FGF-21) in Peritoneal Dialysis Patients: Natural History and Metabolic Implications.
Authors:	González, Elena Díez, Juan J Bajo, M Auxiliadora del Peso, Gloria Grande, Cristina Rodríguez, Olaia Díaz-Almirón, Mariana Iglesias, Pedro Selgas, Rafael View more
Mesh:	Blood Glucose Female Fibroblast Growth Factors Glucose Humans Kidney Male Middle Aged Peritoneal Dialysis Time Factors Uremia View more
Issue Date:	2016
Citation:	PLoS ONE.2016;(11)3:e0151698
Abstract:	Human fibroblast growth factor 21 (FGF-21) is an endocrine liver hormone that stimulates adipocyte glucose uptake independently of insulin, suppresses hepatic glucose production and is involved in the regulation of body fat. Peritoneal dialysis (PD) patients suffer potential interference with FGF-21 status with as yet unknown repercussions.
PMID:	26986485
URI:	https://hdl.handle.net/20.500.12530/27145
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos Fundaciones e Institutos de Investigación > IIS H. U. Ramón y Cajal > Artículos Hospitales > H. U. La Paz > Artículos

Files in This Item:

File	Description	Size	Format
PMC4795603.pdf		909.67 kB	Adobe PDF	View/Open